MYCENAX BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.5 TWD | -3.95% |
|
-8.80% | +19.05% |
| 14/03 | Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 13/03 | Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer | CI |
Chart calendar Mycenax Biotech Inc.
64b0882b5f24461f8aa.8rfgUAf9HMT5X6GoviZyNTPubxZlmXkaX_sXYqCtc5E.tIKJP0-ORqfPG_bi-3Y6bH6IPH0T3ytjKc5yOvaeNfCk3oU-NKJp878Jyg~c89a0bcdb3545846dae15cec4c062c09
Upcoming events on Mycenax Biotech Inc.
Past events on Mycenax Biotech Inc.
| 10/05/2024 | Q1 2024 Earnings Release (Projected) |
| 09/04/2024 06:46 am | March 2024 Sales and Revenue Release |
| 20/03/2024 02:59 pm | Q4 2023 Earnings Release |
| 08/03/2024 | February 2024 Sales and Revenue Release |
| 07/02/2024 | January 2024 Sales and Revenue Release |
| 09/01/2024 | December 2023 Sales and Revenue Release |
| 14/11/2023 | Q3 2023 Earnings Release |
| 09/11/2023 | October 2023 Sales and Revenue Release |
| 11/10/2023 11:37 am | September 2023 Sales and Revenue Release |
| 06/09/2023 02:31 pm | August 2023 Sales and Revenue Release |
| 14/08/2023 02:35 pm | Q2 2023 Earnings Release |
| 09/08/2023 | July 2023 Sales and Revenue Release |
| 07/07/2023 | June 2023 Sales and Revenue Release |
| 20/06/2023 | Annual General Meeting |
| 06/06/2023 | May 2023 Sales and Revenue Release |
| 27/12/2022 07:30 am | Extraordinary Shareholders Meeting |
| 11/11/2022 07:08 am | Q3 2022 Earnings Release |
| 09/11/2016 | Q3 2016 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,00 | 665 661 0.66% | 0,00 | 732 622 17.73% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 0,00 - |
|
EBIT Million TWD | Released Forecast Spread | 0,00 | 35,4 130 -72.77% | 0,00 | -445 -299 -48.83% |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | -463 -290 -59.6% |
|
Net income Million TWD | Released Forecast Spread | -218 | 0,00 0,00 - | -89,9 | -454 -291 -55.89% |
|
EPS TWD | Released Forecast Spread | -1,74 | 0,00 0,00 - | -0,61 | -2,74 -1,88 -45.74% |
| Announcement Date | 19/03/20 | 29/03/21 | 24/03/22 | 14/03/23 |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 159 91,0 75.01% | 196 154 27.19% | |
|
EBIT Million TWD | Released Forecast Spread | -163 -89,0 -83.37% | -175 -103 -69.68% | |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -176 -90,0 -95.76% | -189 -103 -83.6% | |
|
Net income Million TWD | Released Forecast Spread | -116 | -173 -90,0 -92.19% | -183 -103 -77.22% |
|
EPS TWD | Released Forecast Spread | -0,76 | -1,12 -0,44 -154.55% | -0,98 -0,50 -96% |
| Announcement Date | 11/08/22 | 11/11/22 | 14/03/23 |
More events
Past sector events for Mycenax Biotech Inc.
| Today | BIOCON LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 14/05/2024 | IMMATICS N.V.: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 14/05/2024 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 14/05/2024 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 01:31 am | ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 | PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release |
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4726 Stock
- Calendar Mycenax Biotech Inc.